Heart Disease News and Research

Latest Heart Disease News and Research

New minimally invasive laser treatment saves the lives of twins with TTTS

As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.

13 Nov 2009

Masked hypertension in CKD children can increase risk of heart disease

Many children with chronic kidney disease (CKD) who show normal blood pressure readings at the doctor's office have high blood pressure when tested at home, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

13 Nov 2009

Changes in CMS reimbursement to accelerate demand for cardiac PET imaging

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, expects the evolution from cardiac SPECT to cardiac PET imaging will be greatly accelerated with the recent changes in reimbursement from the Centers for Medicare & Medicaid Services (CMS) set for 2010.

13 Nov 2009

Cardiac Science and Cambridge Heart team up to develop MTWA module

Cardiac Science Corporation [NASDAQ: CSCX], a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, and Cambridge Heart, Inc., [OTCBB-CAMH], a developer of noninvasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest, today announced a partnership pursuant to a Development, Supply and Distribution Agreement Cambridge Heart previously announced on June 23, 2009.

13 Nov 2009

LA BioMed to participate in a national study of the effectiveness of testosterone

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

13 Nov 2009

Results from first-in-man study of NO-donating HMG-CoA Reductase Inhibitor released

NicOx S.A. today announced that a phase 1b, first-in-man study for NCX 6560, versus placebo and Lipitor® (atorvastatin), has met its primary and secondary objectives. The top-line results demonstrated very good safety and tolerability for all the tested doses of NCX 6560, as well as the expected cholesterol lowering profile.

13 Nov 2009

NJIT's EDC companies receive $1.4M funding from the New Jersey Commission on Science and Technology

A drug to stop bleeding during a brain injury and a mattress that will prevent bedsores are among the scientific discoveries at NJIT that received earlier this week more than a million dollars in funding from the New Jersey Commission on Science and Technology. The discoveries are the work of five early stage companies based at NJIT's Enterprise Development Center (EDC), the state's oldest business incubator program.

13 Nov 2009

BMC and Clear One Health Plans team up to offer first Focused Patient Care Model

Bend Memorial Clinic (BMC), the largest provider of quality, comprehensive and convenient physician healthcare in Central Oregon, has joined with Clear One Health Plans to offer the region’s first Focused Patient Care Model, similar to a Medical Home Model, beginning January 1, 2010. BMC’s team of more than 100 physicians and other providers care for approximately 3,800 Clear One Medicare Advantage members all of whom will qualify for the program.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

ARYx Therapeutics announces operating results for the third quarter of 2009

ARYx Therapeutics, Inc. today reported results of operations and provided a general business update for the third quarter ended September 30, 2009.

12 Nov 2009

Will the health bill bend costs?

One cause for health reform anxiety is that no one is sure whether the legislation would achieve one of its most critical goals: lowering health care costs.

12 Nov 2009

New Cat B 750 FAST imaging agent launched by VisEn Medical

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.

12 Nov 2009

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE), announced today that the 3M™ Littmann® Electronic Stethoscope Model 3200 with Zargis Cardioscan™ software was named Popular Science’s “Innovation of the Year.” This prestigious honor, part of the publication’s annual “Best of What’s New Awards,” highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year.

12 Nov 2009

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Vermillion, Inc., a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for ovarian cancer.

12 Nov 2009

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Bridge Worldwide announced today that Jonathan Richman, Director of Strategic Planning, will present at the public hearing on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools," to be held on November 12 and 13, 2009, from 8 a.m. to 5 p.m., at the National Transportation Safety Board Conference Center in Washington, D.C. Richman is scheduled to speak on Friday, November 13, at 11:40 a.m. and 2:40 p.m. for 10 minutes per time slot. To listen to a free, live webcast of the hearing, go to: www.capitolconnection.net/capcon/fda/111209/FDAlive.htm.

12 Nov 2009

Frequent heartburn is painful and impacts the quality of life: Study

While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.

12 Nov 2009

Pioneering cardiologist and inventor in heart medicine passed away

William Ganz, M.D., an internationally-recognized leader and inventor in heart medicine, died Tuesday night of natural causes. He was 90.

12 Nov 2009

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Four macaque monkeys that received injections of genes for a protein called follistatin into upper leg muscles experienced pronounced and durable increases in muscle size and strength and no adverse effects, the Muscular Dystrophy Association (MDA) announced today. The findings could have implications particularly for injured and aging people worldwide; and for tens of millions experiencing muscle loss associated with cancer, AIDs and muscle diseases.

12 Nov 2009

Heart Disease News and Research

Latest Heart Disease News and Research

New minimally invasive laser treatment saves the lives of twins with TTTS

Masked hypertension in CKD children can increase risk of heart disease

Changes in CMS reimbursement to accelerate demand for cardiac PET imaging

Cardiac Science and Cambridge Heart team up to develop MTWA module

LA BioMed to participate in a national study of the effectiveness of testosterone

Results from first-in-man study of NO-donating HMG-CoA Reductase Inhibitor released

NJIT's EDC companies receive $1.4M funding from the New Jersey Commission on Science and Technology

BMC and Clear One Health Plans team up to offer first Focused Patient Care Model

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

ARYx Therapeutics announces operating results for the third quarter of 2009

Will the health bill bend costs?

New Cat B 750 FAST imaging agent launched by VisEn Medical

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Frequent heartburn is painful and impacts the quality of life: Study

Pioneering cardiologist and inventor in heart medicine passed away

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in